SCHEMBL4048356

SCHEMBL4048356

NC1CCC(c2ccccc2)(N2CCOCC2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.47
SLC6A2 P23975 2/20 0.47
SLC6A4 P31645 2/20 0.47
SLC6A3 Q01959 2/20 0.47
GRIN2D O15399 1/20 0.47
GRIN3B O60391 1/20 0.47
CYP2B6 P20813 1/20 0.47
PRCP P42785 1/20 0.47
GRIN1 Q05586 1/20 0.47
KCNH2 Q12809 1/20 0.47
GRIN2A Q12879 1/20 0.47
GRIN2B Q13224 1/20 0.47
GRIN2C Q14957 1/20 0.47
GRIN3A Q8TCU5 1/20 0.47
OPRM1 P35372 2/20 0.46
OPRD1 P41143 1/20 0.46
OPRL1 P41146 4/20 0.45
SLC6A9 P48067 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2875830 0.85 SIGMAR1 (0.61) SIGMAR1SLC6A2SLC6A4SLC6A3GRIN2D
SCHEMBL4126158 0.85 SIGMAR1 (0.66) SIGMAR1SLC6A2SLC6A4SLC6A3GRIN2D
SCHEMBL4049565 0.84 SIGMAR1 (0.69) SIGMAR1SLC6A2SLC6A4SLC6A3GRIN2D
SCHEMBL4125739 0.84 SLC6A2 (0.44) SIGMAR1SLC6A2SLC6A4SLC6A3GRIN2D
SCHEMBL4048354 0.81 SLC6A2 (0.44) SIGMAR1SLC6A2SLC6A4SLC6A3GRIN2D
SCHEMBL7388493 0.80 SIGMAR1 (0.73) SIGMAR1SLC6A2SLC6A4SLC6A3GRIN2D
SCHEMBL9128229 0.78 SIGMAR1 (0.69) SIGMAR1SLC6A2SLC6A4SLC6A3GRIN2D
SCHEMBL7094401 0.78 SIGMAR1 (0.69) SIGMAR1SLC6A2SLC6A4SLC6A3GRIN2D
SCHEMBL10819368 0.78 GRIN2D (0.50) SIGMAR1SLC6A2SLC6A4SLC6A3GRIN2D
SCHEMBL27678993 0.78 SIGMAR1 (0.50) SIGMAR1SLC6A2SLC6A4SLC6A3GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751088-B1 OXO-SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-10-08 EP claimed
EP-1745009-B1 HETEROARYL SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2012-11-14 EP claimed
US-7476763-B2 Oxo-substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2009-01-13 US claimed
US-20070088034-A1 Oxo-substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-04-19 US claimed
US-20090253669-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-08 US disclosed
US-20090253669-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-08 US disclosed
US-20090253669-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-08 US disclosed
US-7476763-B2 Oxo-substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2009-01-13 US disclosed
US-20070088034-A1 Oxo-substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253669-A1 Substituted Sulfonamide Compounds SULT2A1, STS, SULT1A1 SIGMAR1 1349/4885SLC6A2 1720/4885SLC6A4 986/4885
US-20070088034-A1 Oxo-substituted cyclohexyl-1,4-diamine compounds AOC1, ODC1, OTC SIGMAR1 1889/4885SLC6A2 1249/4885SLC6A4 1151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.